April is MENA Heritage Month, and we're honored to celebrate the rich history and culture of Middle Eastern and North African (MENA) communities. The MENA region spans a vast and diverse geography, encompassing a wealth of languages, traditions and perspectives that have shaped civilization for thousands of years. This month is an opportunity to learn, reflect and celebrate this heritage together. We're grateful to VIBE (Vertex Includes Boundless Ethnicities), our employee resource network, for leading the way in recognizing this important month and bringing our community closer together. #MENAHeritageMonth
Vertex Pharmaceuticals
Biotechnology Research
Boston, MA 577,019 followers
The Science of Possibility
About us
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and has made significant advancements in cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain — and continues to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1. Our global headquarters is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/
- Website
-
https://www.vrtx.com/
External link for Vertex Pharmaceuticals
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Boston, MA
- Type
- Public Company
- Founded
- 1989
- Specialties
- cystic fibrosis, APOL1-mediated kidney diseases, sickle cell disease, beta thalassemia, Duchenne muscular dystrophy, type 1 diabetes mellitus, and Pain
Locations
Employees at Vertex Pharmaceuticals
Updates
-
Advancing kidney health takes partnership. This National Kidney Month, Team Vertex was proud to stand with the National Kidney Foundation New England Chapter at their annual Honors Event and Evening of Giving. For five years, we’ve supported this community-driven event alongside advocates, caregivers, and leaders working to expand education, resources, and support for people living with kidney disease. We’re grateful for National Kidney Foundation’s leadership — and committed to continuing this work together, in kidney month and beyond. #NationalKidneyMonth #WorldKidneyDay
-
-
Our teams had the privilege of participating in the 52nd Annual European Society for Blood and Marrow Transplantation (EBMT) Meeting. It was an incredible opportunity to connect with our peers in this space as we work to bring hope to patients with sickle cell disease (SCD) and transfusion-dependent beta thalassemia (TDT). Learn more about our work in SCD and TDT: https://lnkd.in/ebztA3xN #EBMT26
-
-
Well-deserved congratulations to Alex Chesler on being elected to this year’s #AAASFellow class for his distinguished contributions to the field of touch and pain sensation. This recognition, among the highest distinctions in the scientific community, reflects Alex’s outstanding contributions to science and his commitment to advancing discoveries that can make a meaningful difference for patients. Congrats to Alex and all the honorees in the 2025 AAAS Fellows class!
-
-
The Vertex ANZ team walked alongside Rare Cancers Australia and the community over the weekend to raise funds in the annual #KosiChallenge. This powerful event brings people together to support Australians affected by rare and less common cancers by climbing to the summit of Australia's highest peak, Mount Kosciuszko. We're proud to support a cause that touches all of us, through our own experiences or those of someone we care about. Congratulations to Rare Cancers Australia for such a meaningful event, and a heartfelt thank you to all who climbed, fundraised and supported the cause. #KosiChallenge #RareCancersAustralia
-
-
For people living with serious kidney diseases, the disease can be asymptomatic and may go unnoticed, progressing silently for years. That’s why addressing unmet needs and improving patient outcomes is essential. Our partners like the National Kidney Foundation are advancing important progress for people with serious kidney diseases through initiatives like the “75+You” campaign, focused on impacting the lives of 75 million people by 2030. Learn more about the project: https://lnkd.in/gKxaYiwT #NationalKidneyMonth #KidneyHealth
-
Meaningful progress happens when expertise is shared and disciplines intersect. That spirit was on full display at #NSBE2026, where our APOL1-mediated kidney disease (AMKD) spokesperson Alonzo Mourning joined NSBE CEO Janeen Uzzell, Vertex’s Dr. Stacy Johnson and American Kidney Fund CEO LaVarne Burton for a powerful conversation about AMKD and the importance of proactive wellness. Thank you to National Society of Black Engineers for having us! Learn more about AMKD at https://lnkd.in/e8zFgrrX.
-
-
-
-
-
+1
-
-
We have great news: we have been recognized as one of Great Place To Work’s Best Employers in Germany 2026! This award is particularly meaningful, because it’s based on direct feedback from our employees. We’re honored that our commitment to creating exceptional workplaces has been acknowledged — where the most talented and dedicated people come together to advance science and improve the lives of people living with serious diseases around the world.
-
-
We’re excited to join the 52nd Annual European Society for Blood and Marrow Transplantation (EBMT) Meeting alongside the scientific and patient community to share insights about advances in sickle cell disease and transfusion-dependent beta thalassemia. Learn more about our work: https://lnkd.in/ebztA3xN #EBMT26
-
-
Amplifying voices and unlocking new perspectives — that’s the purpose of VIBE (Vertex Includes Boundless Ethnicities), one of our global employee resource networks. With a vision of creating an innovative and inclusive environment where all employees can thrive, discover how VIBE strengthens innovation, energizes leaders and enhances our special culture: https://lnkd.in/ekypUp5q